Alligator Bioscience Announces Publication Highlighting Phase 1 Mitazalimab Data in Solid Tumors in Peer-Reviewed Journal “Investigational New Drugs”
Data confirm mitazalimab's manageable safety profile via a thorough dose-escalation approach via intravenous administration Pharmacokin ...